The resistance of hepatitis C virus (HCV) to direct-acting antiviral agents, used in chronic treatment, consists a natural process resulting from resistance-associated substitutions (RASs) at specific amino acid regions. To identify and establish the prevalence RASs NS3 gene patients with state Pará, northern Brazil. Molecular analysis was performed on total 35 infected HCV genotype 1, who were...

Chronic hepatitis C infection is a worldwide health problem because it causes chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Chronic liver diseases may induce several oral manifestations due to impairment of coagulation, thrombocytopenia or association with diabetes mellitus but hepatic C virus can give rise to a broad spectrum of nonhepatic manifestations. Aim. The purpose of this...

AIM The purpose of this study was to compare the distribution of interleukin (IL)-28B genotypes between Iranian healthy individuals and patients with chronic hepatitis C based on the genotype. BACKGROUND Polymorphisms in the region of IL-28B gene have been identified as the strongest genetic pretreatment predictor of sustained virological response (SVR) in hepatitis C infection. PATIENTS AN...

conclusions erα expression in liver was inversely correlated with liver fibrosis among patients infected with chronic hcv genotype 1b. patients and methods all the consecutive patients who received the same standard treatment protocol for hcv genotype 1b were subdivided into two subgroups according to their fibrosis scores as fibrotic stages < 2 in mild fibrosis group and fibrotic stages ≥ 2 in...

Introduction: Chronic hepatitis C virus (HCV) infection leads to a complex interplay with adaptive immune cells that may result in B cell dyscrasias such as type II mixed cryoglobulinemia and lymphoma. The introduction of direct-acting antiviral (DAA) therapy has reduced the burden severe liver damage its clinical consequences. However, effect viral elimination on extrahepatic manifestations HC...

BACKGROUND The measurement of hepatitis C virus core antigen (HCV-coreAg) has been shown to be an indicator of active HCV infection. The aim of the present study was 1) to investigate the stability and effectiveness of HCV-coreAg and HCV-RNA quantification in HCV infection with or without HIV-1 coinfection, 2) to explore the association between the HCV-coreAg/HCV-RNA (Ag/RNA) ratio and the immu...

The prevalence of hepatitis C virus (HCV) infection is high in patients who are on chronic hemodialysis, but the role of HCV infection and HCV-related liver disease in the mortality of these patients has not been shown. Therefore, we conducted a prospective cohort study of 1470 patients who were on chronic hemodialysis (17 to 89 yr old) from 16 dialysis centers in Japan. Among them, 276 patient...

Chronic Hepatitis C (HCV) infection is an important cause of morbidity and mortality in patients with end-stage renal disease. Renal transplantation confers a survival advantage in HCV-infected patients. Renal transplant candidates with serologic evidence of HCV infection should undergo a liver biopsy to assess for fibrosis and cirrhosis. Patients with Metavir fibrosis score ≤3 and compensated ...

BACKGROUND Chronic hepatitis C virus (HCV) infection can affect multiple organ systems and cause a variety of extrahepatic manifestations (EMs). We sought to assess the constituent ratio of EMs in Chinese patients with chronic HCV infection and identify the clinical and biological factors associated with EM. METHODS The medical records of 297 patients with chronic HCV infection were analyzed ...